© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bupropion Hydrochloride stands out as a chemical used both in clinical settings and in industry, recognized for its role in pharmaceuticals, particularly as an antidepressant and smoking cessation aid. The compound’s strong presence in health care owes much to its unique structure and physical characteristics. Holding the HS Code 29333900, Bupropion Hydrochloride represents more than a piece of pharmaceutical inventory; its manufacture and regulation bear on both global trade and public safety. Laboratories classify it as a raw material subject to strict controls, and in medical environments it remains safeguarded due to its psychotropic effects and potential misuse.
The structure of Bupropion Hydrochloride features a halogenated aromatic ring integrated with a tert-butylamino group and a ketone. This arrangement sets it apart from other agents in the aminoketone family and permits its clinical use in mood and behavioral therapies. With a molecular formula C13H18ClNO•HCl, the compound is composed of carbon, hydrogen, nitrogen, oxygen, and chlorine atoms. Chemists work with a molecular weight near 276.2 grams per mole. The hydrochloride addition heightens the molecule’s solubility in water, ensuring easier formulation in tablets and solutions. Investigation reveals a repeatable crystalline configuration under microscopic analysis, offering evidence of its authenticity and levels of purity during pharmaceutical production.
Bupropion Hydrochloride takes on a white or off-white, crystalline powder form, with a tendency to form flakes under specific production methods. Handling the substance uncovers a solid with moderate density. Typical values show a specific gravity near 1.1 to 1.2 grams per cubic centimeter. This powder dissolves well in water (especially warm), with solubility benefited by its hydrochloride form, and much less so in nonpolar solvents like hexane. The taste is often reported as bitter; the compound shows stability at room temperature and maintains crystalline integrity in dry conditions. In manufacturing, powder, flakes, and occasionally pearls represent the common appearances prior to final dosage formation, while aqueous solutions support routine lab applications.
Chemically, Bupropion Hydrochloride demonstrates stability under neutral and slightly acidic conditions. Thermal decomposition starts at elevated temperatures near 240°C, with breakdown products that include potentially hazardous gases. Direct exposure to strong bases or oxidizing agents is discouraged. The material reacts safely under standard pharmaceutical production protocols, but workers in chemical synthesis or compounding often wear gloves and protective eyewear, knowing skin contact or inhalation produces irritation or other mild symptoms. Some evidence points to harmful effects at high concentrations, so dosing always sticks to carefully measured parameters set by pharmacopoeia standards. Long-term handling calls for ventilation and routine inspections of storage containers for moisture intrusion, as water may alter physical properties and reduce effectiveness.
Sourcing high-quality Bupropion Hydrochloride starts with careful selection of precursor chemicals and close attention to reaction conditions. Pharma-grade material goes through extensive purification, using solvents and crystallization methods to remove trace impurities. Reliable manufacturers provide batch-specific certificates of analysis, showing precise data on melting point, residual solvents, heavy metal content, and water percentage by weight. Analytical labs test for molecular consistency using infrared (IR) spectroscopy and high-performance liquid chromatography (HPLC), comparing test samples to authentic reference standards. Every batch receives a specific lot number tied to production records, supporting traceability from raw material to packaged pharmaceutical products. Chronic shortages or supply chain issues often trigger concern among pharmacists and doctors, making transparent reporting and regulatory supervision necessary for uninterrupted patient care.
All personnel handling Bupropion Hydrochloride work under guidelines provided by chemical safety organizations and workplace safety regulations. Inhalation risk, accidental skin absorption, and dust inhalation drive most of the hazard concerns. Chemical safety data sheets (SDS) advise spill cleanup with damp cloths, careful disposal, and the use of chemical fume hoods. The compound carries labels for harmful and hazardous substances under international classification, even at levels found in bulk raw material shipments. Emergency instructions for accidental ingestion or eye contact call for medical evaluation and symptomatic treatment. In nearly every plant or pharmacy, warning labels and training slides highlight harmful effects, helping new workers recognize why controlled storage and responsible disposal matter to their safety and health.
Global movement of Bupropion Hydrochloride often faces regulatory scrutiny due to its use as a drug substance and its potential abuse. Customs offices check HS Codes to validate cargo legitimacy and compliance. In the United States, and most parts of the European Union, importers and exporters show proof of licensure and end-user declarations. These documents help regulatory agencies trace shipments and ensure only approved pharmaceutical manufacturers secure access. Without this level of control, counterfeit or substandard material might enter the distribution chain, undermining patient trust, as seen in previous decades with recalls linked to foreign-sourced raw materials. Each year, revised import statistics help governments plan for shortages or surpluses, shaping future health policy around real-world drug availability.
No matter how often people discuss drug safety, raw material control, or chemical hazards, the real impact shows up with patients and providers on the front lines. Bupropion Hydrochloride’s journey from pure crystal powder to finished pill reflects what matters in pharmaceutical quality: absolute material traceability, rigorous purity testing, and clear chemical property documentation. When supply chain disruptions threaten access, or patchy regulation allows poor-grade raw material into pharmacy channels, lives may hang in the balance. The story of Bupropion Hydrochloride remains a lesson in vigilance: everyone from chemical processors in raw material factories to community pharmacists plays a role in making sure only safe, well-documented medicine gets to those in need. Real solutions grow out of transparent sourcing, open testing protocols, regular staff training, and steady enforcement, helping keep patients safe and manufacturers accountable, as the chemical’s profile evolves with each new scientific discovery or regulatory change.
